Eli Lilly's performance in the biopharmaceutical sector reflects its strong market position, despite facing challenges. The ...

At the end of December 2024, ASMPT had net cash, having ended nine of the past 13 years in a net cash position. Three company acquisitions in 2018 and an industry downturn in the first half of 2019 ...

Furthermore, we're encouraged that Amer is decentralizing its innovation and marketing efforts to better resonate with the varied preferences of global consumers. This empowers individual brands to ...

EZZ Life Science reports record revenue from operating expenses of $30.3 million during H2 FY25 as progress made on US ...

First Solar achieved a revenue beat in its most recent earnings but missed EPS expectations, highlighting a mixed performance ...